cannabidiol – CFN Media

The Impact of Positive Phase 2 Trial Results on a Smaller Company

A few weeks back, we covered the effect an Orphan Drug Designation…

Robin Lefferts
March 12, 2024

The Impact of Orphan Drug Development on a Smaller Company

Orphan drugs treat conditions with less than 200,000 patients annually in the…

Robin Lefferts
February 6, 2024

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Toronto, Ontario–(Newsfile Corp. – November 16, 2023) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Ryan Allway
November 16, 2023

Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

BERWYN, Pa., January 04, 2023–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:…

Ryan Allway
January 4, 2023

Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)

–VRPX Intranasal Cannabidiol Product Candidate for Management of Epilepsy in Children and…

Ryan Allway
December 14, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Tech Stocks

Aduro Clean Technologies Selected to Present at Chemelot Circular Hub Event in the Netherlands

LONDON, Ontario, May 09, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
May 9, 2024

Top News

International Land Alliance Announces Sales and Marketing Office in Monterrey

SAN DIEGO, CALIFORNIA, May 08, 2024 (GLOBE NEWSWIRE) — International Land…

Ryan Allway
May 8, 2024

Ispire Technologies Inc. Schedules Fiscal Third Quarter 2024 Earnings Conference Call

LOS ANGELES, May 8, 2024 /PRNewswire/ — Ispire Technology…

Ryan Allway
May 8, 2024

Mining Stocks

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement

Strategic Transaction Empowers Company’s Growth Trajectory VANCOUVER, BC /…

Ryan Allway
May 8, 2024